ABI-5366-101: Subjects with Recurrent Genital Herpes

CONDITION

Other

GENDER

All

AGE GROUP

From 18

to 60 years

STATUS

Active, not recruiting

A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 with Recurrent Genital Herpes

CONTACT DETAILS

Clinical Trial Site: East Sydney Doctors
Phone Number: 02 9332 2531 Email: trials@eastsydneydoctors.com.au Location: 102 Burton Street, Darlinghurst NSW, Australia

Studies Contact Form

  • This field is hidden when viewing the form

Approved By: Bellberry limited              

Clinical Trial Registry Link: